Insulin of the Future?

Last month, my Dad sent a rather exciting (to me) email.  I knew it had to be something interesting or something that pertained to me, as he emails so little, as is.  I always click on it immediately when I see his name :) 
When I opened it, it was a link to a news article... 

It was about breathable Insulin called Afrezza produced by the company MannKind that

would be (hopefully) by FDA approved in early 2014.  I (like many others) inject myself daily 4-6 times a day, and while it is not painful, it is a PAIN to deal with.  So I must admit when I read this, it really grabbed me and pulled me threw a world of Googling and reading as much as I could...and I discovered a lot that other would maybe find interesting..

Although, many case studies on Afrezza have been taking place since 2007 and results show a very positive outcome and review of this product, I found that breathable insulin is nothing new to the field of Diabetes... 
Did you know there was a breathable Insulin called Exubera until 2007?  While it never gained any traction in the medical market, it cited 'low sales due to insurance companies not picking it up' as it's main failure.  Afrezza is said to have that cat in the bag cat bagged, with the same price as the Insulin 'pens' ..promising a better outcome and to be a better overall drug.  Taken 12-14 minutes before meal times, it was comparable to a normal person's pancreas and had the same results.  Oh, and research for any long term stress it would  have on your lungs? ..seems to be looking good since it is an insulin and not a steroid of any shape or form.

The overall outlook for the MannKind company must look good.  With the news of this new breathable insulin possibly being approved soon, the stock for this company soared 18% ... Not to mention, the CEO - Alfred Mann, has put about 930 million dollars of his own money in the company over the years.  Sounds like he has something to believe in!